Filing Details
- Accession Number:
- 0001209191-23-004732
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-01-24 20:08:49
- Reporting Period:
- 2023-01-20
- Accepted Time:
- 2023-01-24 20:08:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1649989 | Outlook Therapeutics Inc. | OTLK | Biological Products, (No Disgnostic Substances) (2836) | 383982704 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1760511 | Jeff Evanson | C/O Outlook Therapeutics, Inc. 485 Route 1 South, Bldg F, Suite 320 Iselin NJ 08830 | Chief Commercial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-01-20 | 267,000 | $1.11 | 745,975 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These shares were sold to cover taxes upon lapse of Issuer's repurchase right as to 75% of the shares as provided in that certain Consulting Agreement dated January 27, 2020.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 - $1.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Billionaire Hedge Funds
